Estradiol patches and blood clots: what the evidence shows

Why the route matters

When you swallow estrogen, it is absorbed from the gut and passes through the liver before it reaches the rest of your body. That first pass prompts the liver to make more of several proteins involved in clotting, which is thought to explain why estrogen pills increase the risk of deep vein thrombosis and pulmonary embolism.

A patch releases estradiol through the skin directly into the bloodstream. The liver still sees estrogen eventually, but at lower, steadier concentrations, and the effect on clotting proteins appears much smaller. The Menopause Society notes that oral hormone therapy raises clot risk and that transdermal estrogen may carry a lower risk.

What the studies found

One of the largest analyses comes from two linked UK primary care databases, published in The BMJ in 2019. Researchers compared more than 80,000 women aged 40 to 79 who had a venous blood clot with nearly 400,000 matched women who did not.

Oral hormone therapy was associated with a higher clot risk than no hormone therapy, for both estrogen-only and combined pills. Transdermal therapy was not associated with an increased risk. Among pills, estradiol carried less risk than conjugated equine estrogens, and the combination with the highest risk included medroxyprogesterone acetate.

These are observational results, which means women were not randomly assigned to a route. Women given patches may have differed in ways the researchers could not fully adjust for. Even so, the findings line up with earlier French research and with how the biology is understood.

The progestogen part of the picture

If you have a uterus, you need a progestogen with your estrogen. The type appears to matter for clots. In the BMJ analysis, regimens with medroxyprogesterone acetate carried the highest risk, while others carried less.

HealifyMD clinicians generally pair estradiol with oral micronized progesterone, which has not been linked to the same rise in clot risk in available studies. The evidence here is also observational, and your clinician will explain the trade-offs.

If you have clot risk factors

A patch does not erase your own risk; it avoids adding much to it. How your clinician approaches the decision depends on what the risk factor is:

• Higher body weight: a patch is commonly preferred over pills, because weight itself raises clot risk
• Inherited clotting tendency without a past clot, such as factor V Leiden: a patch may be considered with careful review and sometimes specialist input
• A previous clot: this usually requires a specialist opinion, and many women in this group are steered toward non-hormonal treatment or local vaginal estrogen
• Smoking: raises clot and stroke risk on its own; quitting is part of the plan
• Upcoming surgery or immobility: your clinician may advise pausing estrogen beforehand

Who should not use the patch

Some situations rule out systemic estrogen by any route, at least until a specialist weighs in. These include an active or recent blood clot, a recent stroke or heart attack, current or past estrogen-sensitive cancer, and unexplained vaginal bleeding. For women in these groups who have vaginal symptoms, low-dose vaginal estrogen or non-hormonal options may still be possible.

Strokes are a separate question

Strokes are caused by different processes than leg and lung clots, and the evidence is less complete. The Menopause Society notes that stroke risk rises with both estrogen-alone and combined therapy and falls soon after stopping. Some data suggest lower-dose transdermal estrogen may have less effect on stroke risk than pills, but this has not been settled by randomized trials.

Your blood pressure, migraine history, diabetes and smoking status all feed into your clinician's assessment.

What the updated labels say

In February 2026, FDA approved label changes for the first six menopausal hormone products, removing statements about cardiovascular disease, breast cancer and probable dementia from the boxed warning. Many patch labels had not yet been updated at the time of writing, so you may still see the older boxed warning, which names blood clots and stroke.

Either way, clots remain a real but uncommon risk to discuss. Know the warning signs: pain or swelling in one leg, sudden shortness of breath, chest pain, or sudden weakness, confusion or trouble speaking. Any of these needs emergency care.